Bio-Min 牙膏管理白斑病变有效性的随机对照试验
该单中心、双盲随机对照试验旨在评估含氟生物活性玻璃牙膏(BioMin™)对正畸治疗后牙釉质脱矿所致白斑病变的再矿化效果。研究对象为完成正畸治疗的年轻人,试验注册号 ISRCTN 14479893,于 2020 年 5 月 14 日注册。原文未报告试验结果。
要点
- 白斑病变是固定矫治器正畸治疗的常见副作用,表现为牙釉质表层脱矿。
- 低剂量氟化物再矿化联合最佳口腔卫生和饮食已被推荐用于管理白斑病变。
- 本试验评估含氟生物活性玻璃牙膏(BioMin™)对正畸后脱矿白斑病变的再矿化能力。
核心结论
- 原文未报告试验结果或结论。
研究设计与样本
- 单中心、双盲随机对照试验,评估 Bio-Min 牙膏对完成正畸治疗的年轻人牙齿上形成的白斑病变的干预效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: White spot lesions (WSL) are common side effects of orthodontic treatment with fixed appliances, in which the surface layer of enamel is demineralised. Thus, remineralisation, that is a partial or complete reversal, of these lesions can occur as they affect the surface enamel. Remineralisation with low-dose fluoride, in addition to optimal oral hygiene and diet, has been recommended to manage WSL. The aim of the planned trial is to assess the effectiveness of a fluoride-containing bioactive glass toothpaste (BioMin™) in its ability to remineralise post-orthodontic demineralised WSL. METHODS: A single-centre, double-blind randomised clinical trial to assess intervention with Bio-Min toothpaste on WSL forming on the teeth of young people completing orthodontic treatment. DISCUSSION: Remineralisation of WSL can vary depending on the individual and the site of the lesion. There is a range of oral fluoride delivery methods which include toothpastes, oral rinses, and gel preparations, which can aid remineralisation of these lesions. Identifying effective methods of remineralisation to manage this common and unsightly complication of fixed appliance therapy can improve the health and aesthetics of dentition. TRIAL REGISTRATION: ISRCTN.com International Standard Randomised Controlled Trials Number (ISRCTN) 14479893 . Registered on 14 May 2020.
引用
- Johal A, Keogh A, Bolooki H, et al. The effectiveness of Bio-Min toothpaste in the management of white spot lesions: a randomised control trial. Trials. 2024. PMID: 39256875. doi:10.1186/s13063-024-07990-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。